News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
844,612 Results
Type
Article (86387)
Company Profile (651)
Press Release (757574)
Multimedia
Podcasts (128)
Webinars (14)
Section
Business (232622)
Career Advice (4126)
Deals (39715)
Drug Delivery (129)
Drug Development (90952)
Employer Resources (198)
FDA (18090)
Job Trends (17328)
News (396347)
Policy (39732)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (3000)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (90)
Alliances (56815)
ALS (98)
Alzheimer's disease (1493)
Antibody-drug conjugate (ADC) (148)
Approvals (18056)
Artificial intelligence (293)
Autoimmune disease (27)
Automation (16)
Bankruptcy (405)
Best Places to Work (12630)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (448)
Bladder cancer (70)
Brain cancer (30)
Breast cancer (293)
Cancer (2297)
Cardiovascular disease (197)
Career advice (3532)
Career pathing (34)
CAR-T (164)
Cell therapy (458)
Cervical cancer (21)
Clinical research (73269)
Collaboration (889)
Compensation (535)
Complete response letters (29)
COVID-19 (2858)
CRISPR (45)
C-suite (253)
Cystic fibrosis (106)
Data (2145)
Decentralized trials (2)
Denatured (45)
Depression (52)
Diabetes (282)
Diagnostics (6899)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (133)
Drug pricing (121)
Drug shortages (31)
Duchenne muscular dystrophy (100)
Earnings (96404)
Editorial (42)
Employer branding (25)
Employer resources (167)
Events (129606)
Executive appointments (752)
FDA (19360)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (796)
Gene editing (115)
Generative AI (28)
Gene therapy (335)
GLP-1 (837)
Government (5150)
Grass and pollen (6)
Guidances (51)
Healthcare (20873)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (139)
Indications (29)
Infectious disease (3013)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (97)
Interviews (812)
IPO (17806)
IRA (50)
Job creations (5186)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (548)
Leadership (22)
Legal (10110)
Liver cancer (78)
Lung cancer (334)
Lymphoma (151)
Machine learning (5)
Management (65)
Manufacturing (333)
MASH (72)
Medical device (14602)
Medtech (14607)
Mergers & acquisitions (22427)
Metabolic disorders (758)
Multiple sclerosis (84)
NASH (23)
Neurodegenerative disease (107)
Neuropsychiatric disorders (34)
Neuroscience (2071)
NextGen: Class of 2025 (7667)
Non-profit (5077)
Northern California (2643)
Now hiring (40)
Obesity (410)
Opinion (274)
Ovarian cancer (76)
Pain (93)
Pancreatic cancer (84)
Parkinson's disease (156)
Partnered (23)
Patents (244)
Patient recruitment (108)
Peanut (51)
People (65229)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (22605)
Phase II (31816)
Phase III (23978)
Pipeline (1178)
Policy (163)
Postmarket research (3552)
Preclinical (10155)
Press Release (72)
Prostate cancer (104)
Psychedelics (38)
Radiopharmaceuticals (268)
Rare diseases (416)
Real estate (7391)
Recruiting (75)
Regulatory (26722)
Reports (57)
Research institute (2653)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (4)
RSV (48)
Schizophrenia (76)
Series A (140)
Series B (89)
Service/supplier (27)
Sickle cell disease (58)
Southern California (2295)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4290)
State (2)
Stomach cancer (16)
Supply chain (73)
Tariffs (37)
The Weekly (81)
United States (23894)
Vaccines (792)
Venture capitalists (44)
Weight loss (292)
Women's health (40)
Worklife (19)
Date
Today (225)
Last 7 days (601)
Last 30 days (2679)
Last 365 days (35312)
2025 (10471)
2024 (37819)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (59)
Alaska (7)
Arizona (267)
Arkansas (14)
Asia (50073)
Australia (8823)
California (6189)
Canada (2008)
China (538)
Colorado (274)
Connecticut (286)
Delaware (148)
Europe (114774)
Florida (904)
Georgia (216)
Hawaii (1)
Idaho (64)
Illinois (605)
India (30)
Indiana (325)
Iowa (11)
Japan (162)
Kansas (109)
Kentucky (26)
Louisiana (14)
Maine (67)
Maryland (939)
Massachusetts (4764)
Michigan (235)
Minnesota (412)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (26)
Nevada (62)
New Hampshire (68)
New Jersey (1761)
New Mexico (31)
New York (1759)
North Carolina (1107)
North Dakota (8)
Northern California (2643)
Ohio (209)
Oklahoma (15)
Oregon (46)
Pennsylvania (1370)
Puerto Rico (12)
Rhode Island (35)
South America (1652)
South Carolina (22)
South Dakota (1)
Southern California (2295)
Tennessee (104)
Texas (925)
Utah (184)
Virginia (159)
Washington D.C. (69)
Washington State (590)
West Virginia (3)
Wisconsin (64)
844,612 Results for "cn bio innovations formerly known as zyomyx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CN Bio and Pharmaron Establish Long-Term Strategic Partnership to Develop OOC Technologies on a Global R&D Platform
April 23, 2025
·
2 min read
Press Releases
CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference
February 10, 2025
·
2 min read
Deals
Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
Harmony Biosciences, announced the acquisition of Epygenix Therapeutics, Inc., accelerating its growth strategy by adding a rare epilepsy franchise to its expanding late-stage pipeline of innovative CNS assets.
April 30, 2024
·
9 min read
Press Releases
CN Bio Launches PhysioMimix DILI Assay Kit: Human 24, for Enhanced Preclinical Toxicology Testing
February 4, 2025
·
3 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Neurocrine Biosciences to Present at the Stifel 2025 Virtual CNS Forum
March 12, 2025
·
1 min read
Press Releases
CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
February 19, 2025
·
3 min read
Press Releases
Alto Neuroscience to Participate in the JonesResearch Virtual CNS Day
April 22, 2025
·
1 min read
Press Releases
INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update
March 28, 2025
·
19 min read
Genetown
CN Bio Raises $21 Million USD in First Close of Series B Investment Round
CN Bio, a leading provider of single- and multi-organ microphysiological systems, announced it has raised a $21 million investment in the first close of its Series B fundraising round.
April 23, 2024
·
4 min read
1 of 84,462
Next
